AVITA Medical, Inc. Debt Securities, Available-for-sale, Amortized Cost, Current
AVITA Medical, Inc. (RCEL) had Debt Securities, Available-for-sale, Amortized Cost, Current of $2.00 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Credit Losses
us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostCurrent · last filed 2026-08-06
- 2026-06-30: Debt Securities, Available-for-sale, Amortized Cost, Current $2.00M.
- 2026-03-31: Debt Securities, Available-for-sale, Amortized Cost, Current $5.95M.
- 2025-12-31: Debt Securities, Available-for-sale, Amortized Cost, Current $7.94M.
- 2025-09-30: Debt Securities, Available-for-sale, Amortized Cost, Current $7.89M.
| Period end | Debt Securities, Available-for-sale, Amortized Cost, Current |
|---|---|
| 2026-06-30 | $2.00M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $5.95M 10-Q · filed 2026-05-14 |
| 2025-12-31 | $7.94M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $7.89M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $3.47M 10-Q · filed 2025-08-08 |
| 2025-03-31 | $10.95M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $21.82M 10-K · filed 2026-02-12 |
| 2024-09-30 | $25.73M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $36.62M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $51.23M 10-Q · filed 2024-05-13 |
| 2023-12-31 | $66.84M 10-K · filed 2025-02-13 |
| 2023-09-30 | $9.28M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $28.64M 10-Q · filed 2023-08-10 |
| 2023-03-31 | $45.59M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $61.60M 10-K · filed 2024-02-22 |
| 2022-09-30 | $61.15M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $49.97M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $60.00M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $29.66M 10-K · filed 2023-02-23 |
| 2021-09-30 | $29.70M 10-Q · filed 2021-11-08 |